In the U.S. pharmaceutical industry, companies often allocate disproportionately high budgets to sales forces while underinvesting … Why Pharma Companies Overinvest in Sales and Underinvest in StrategyRead more
Author: Jayshree Gondane
Jayshree Gondane,
BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
Top 7 Go-To-Market Mistakes in Pharma Launches
Bringing a drug to market is often described as one of the most complex and capital-intensive … Top 7 Go-To-Market Mistakes in Pharma LaunchesRead more
Why Real-World Evidence Matters More Than Ever in Pharma
The pharmaceutical industry is undergoing a fundamental shift in how evidence is generated, evaluated, and applied. … Why Real-World Evidence Matters More Than Ever in PharmaRead more
How Lack of Transparency Hurts Patient Trust in Pharma
Trust shapes every interaction between patients and the pharmaceutical industry. It influences whether someone enrolls in … How Lack of Transparency Hurts Patient Trust in PharmaRead more
How Sales and Marketing Misalignment Slows Revenue Growth
In the pharmaceutical industry, sales and marketing teams are critical drivers of revenue growth, yet misalignment … How Sales and Marketing Misalignment Slows Revenue GrowthRead more
Why Pharma Marketing Needs to Be Education-First
In today’s healthcare landscape, traditional marketing tactics focused solely on promotion no longer suffice. Patients, healthcare … Why Pharma Marketing Needs to Be Education-FirstRead more
Why Clinical Trial Diversity Is a Growing Challenge
Clinical trials form the scientific backbone of drug approval in the United States. Every therapy that … Why Clinical Trial Diversity Is a Growing ChallengeRead more
How Digital Transformation Can Speed Up Drug Development
Drug development in the United States remains one of the most complex, time-intensive, and capital-heavy processes … How Digital Transformation Can Speed Up Drug DevelopmentRead more
Why Pharma Companies Lose Momentum After Drug Approval
In the United States pharmaceutical industry, receiving approval from the U.S. Food and Drug Administration is widely regarded … Why Pharma Companies Lose Momentum After Drug ApprovalRead more
How Poor Branding Hurts Pharma Product Launches
In the United States pharmaceutical market, a product launch is one of the most financially and … How Poor Branding Hurts Pharma Product LaunchesRead more